TE_19
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | FRAM |
|---|---|
| TE superfamily | Alu |
| TE order | SINE |
| Gene | C1orf159 |
| Class | Chimeric |
| Coding | Non-coding, Other |
| Tumor-specific score | 0.92 |
| Counts of samples | TCGA_tumor:157; TCGA_normal:4; GTEx:188 |
| TSS | chr1(-):1104812 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_19.11 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1090408,1090428,1091278,1091374,1091472,1091565,1091991,1092103,1104686,1104813 |
| teRNA_19.12 | C1orf159 | Chimeric | Non-coding | Non-coding | chr1(-):1091545,1091565,1091991,1092103,1104686,1104813 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
